Fred Schneider is the Vice President of Sales & Operations at Hamilton Company, where he is redefining what it means to lead in biotech. With a sharp focus on value-driven engagement, Fred challenges traditional sales models by shifting the conversation from features and transactions to impact and transformation. A firm believer that the future of biotech depends on true collaboration, not just product pushing, Fred helps life science companies scale with confidence. He empowers biochemists, process engineers, and procurement leaders to make more informed decisions through strategic consultation, grounded in proven methodologies like the Challenger Model and the Miller Heiman framework. Under Fred’s leadership, his teams don’t just respond to customer needs—they proactively teach, tailor, and take control, bringing insight that challenges assumptions and delivers real differentiation. At Hamilton, Fred oversees the delivery of advanced process analytics solutions—including pH, DO, CO₂, and cell viability sensors—that optimize cell culture, improve fermentation, and drive efficiency. But for Fred, it’s not just about cutting-edge products. It’s about seamless integration, intuitive training, and unmatched support. His goal is to ensure that every innovation Hamilton brings to market is practical, transformative, and rooted in real-world progress. Fred’s approach is guided by a single conviction: the future of biotech isn’t about selling more—it’s about creating more. More efficiency. More precision. More breakthroughs.